A Disintegrin and Metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis

97Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE-: To elucidate the downstream mechanisms of vascular endothelial growth factor receptor 2 (VEGFR2), a key receptor in angiogenesis, which has been associated with atherosclerotic plaque growth and instability. METHODS AND RESULTS-: By using a yeast-2-hybrid assay, we identified A Disintegrin And Metalloprotease 10 (ADAM10) as a novel binding partner of VEGFR2. ADAM10 is a metalloprotease with sheddase activity involved in cell migration; however, its exact function in endothelial cells (ECs), angiogenesis, and atherosclerosis is largely unknown. For the first time to our knowledge, we show ADAM10 expression in human atherosclerotic lesions, associated with plaque progression and neovascularization. We demonstrate ADAM10 expression and activity in ECs to be induced by VEGF; also, ADAM10 mediates the ectodomain shedding of VEGFR2. Furthermore, VEGF induces ADAM10-mediated cleavage of vascular endothelium (VE)-cadherin, which could increase vascular permeability and facilitate EC migration. Indeed, VEGF increases vascular permeability in an ADAM10- and ADAM17-dependent way; inhibition of ADAM10 reduces EC migration and chemotaxis. CONCLUSION-: These data provide the first evidence of ADAM10 expression in atherosclerosis and neovascularization. ADAM10 plays a functional role in VEGF-induced EC function. These data open perspectives for novel therapeutic interventions in vascular diseases. © 2010 American Heart Association, Inc.

References Powered by Scopus

VEGF receptor signalling - In control of vascular function

2677Citations
N/AReaders
Get full text

Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage

1181Citations
N/AReaders
Get full text

Revascularization of ischemic tissues by PLGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

984Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: Novel drug targets with therapeutic potential?

257Citations
N/AReaders
Get full text

The role of ADAM-mediated shedding in vascular biology

179Citations
N/AReaders
Get full text

Metalloproteinases in atherosclerosis

166Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Donners, M. M. P. C., Wolfs, I. M. J., Olieslagers, S., Mohammadi-Motahhari, Z., Tchaikovski, V., Heeneman, S., … Waltenberger, J. (2010). A Disintegrin and Metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(11), 2188–2195. https://doi.org/10.1161/ATVBAHA.110.213124

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 30

60%

Researcher 11

22%

Professor / Associate Prof. 8

16%

Lecturer / Post doc 1

2%

Readers' Discipline

Tooltip

Medicine and Dentistry 17

34%

Agricultural and Biological Sciences 16

32%

Biochemistry, Genetics and Molecular Bi... 15

30%

Materials Science 2

4%

Save time finding and organizing research with Mendeley

Sign up for free